← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2004Last known activity
Jan 11, 2021
Timeline
1990s
- Jun 1, 1996
Steba Biotech S.A.— Founded
Drugs by trial phase (4 distinct, 19 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Cholangiocarcinoma
- Choroidal Neovascularization
- Deglutition Disorders
- Duodenal Ulcer
- Enuresis
- Erectile Dysfunction
- Esophagitis
- Esophagitis, Peptic
- Gastroesophageal Reflux
- Kidney Neoplasms
- Lung Neoplasms
- Macular Degeneration
- Neovascularization, Pathologic
- Prostatic Neoplasms
- Stomach Ulcer
- Ulcer
- Urinary Incontinence
Recent trials (21)
- NCT04620239Lead sponsorPhase 3Jan 11, 2021
- NCT04225299Lead sponsorPhase 3Jan 31, 2020
- NCT03849365Lead sponsorPhase 4Jan 21, 2019
- NCT03315754Lead sponsorPhase 2Oct 2, 2017
- NCT03133650CollaboratorPhase 1Apr 26, 2017
- NCT01573156CollaboratorPhase 1/Phase 2May 1, 2013
- NCT01875393Lead sponsorPhase 3May 1, 2013
- NCT01310894Lead sponsorPhase 3Feb 1, 2011
- NCT01021956Lead sponsorPhase 2Jun 1, 2010
- NCT00975039Lead sponsorPhase 2Sep 1, 2009
- NCT00975429Lead sponsorPhase 2Sep 1, 2009
- NCT00974662Lead sponsorPhase 2Sep 1, 2009
- NCT00946881Lead sponsorPhase 1/Phase 2Jul 1, 2009
- NCT00707356Lead sponsorPhase 2Sep 1, 2008
- NCT00284908Lead sponsorPhase 1Sep 1, 2006
Details
- Founded
- LU Jun 1, 1996
- Last known activity
- Jan 11, 2021